Mobilisation of tumour cells along with CD34+ cells to peripheral blood in multiple myeloma

European Journal of Haematology

Volumn 67, Issue 5-6, 2001, Pages 289-295

  Knudsen, Lene Meldgaard ^a   Rasmussen, Thomas ^a   Nikolaisen, Kirsten ^a   Johnsen, Hans Erik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

CD34 cells; Mobilisation kinetics; Multiple myeloma; Plasma cells

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; MESNA; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKAPHERESIS; MALE; MULTIPLE MYELOMA; PLASMA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL MOBILIZATION; TECHNOLOGY; TUMOR CELL;

ADULT; ANTIGENS, CD34; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL COUNT; CELL SEPARATION; CYCLOPHOSPHAMIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 0035709826     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2001.00504.x     Document Type: Article

References (36)

1. Role of high-dose therapy with peripheral blood progenitor cell support in multiple myeloma
2. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma
3. Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants
4. Comparison of rhG-CSF primed bone marrow and blood stem cell autografts: An analysis of engraftment in malignant lymphomas and solid tumours
5. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: A randomised comparison
6. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone marrow transplantation in lymphoma patients
7. Comparison of G-CSF primed peripheral blood progenitor cells and bone marrow auto transplantation: Clinical assessment and cost-effectiveness
8. Goldstone AH for the Lymphoma Working Party of the EBMT Comparison of peripheral blood stem cell and autologous bone marrow transplantation for lymphoma patients: A case-controlled analysis of the EBMT Registry data
9. Detection of circulating cells in multiple myeloma by a PCR-based method
10. Immunoglobulin gene rearrangement in plasma cell dyscrasias: Detection of small clonal cell populations in peripheral blood and bone marrow
11. + cells in the blood of patients with multiple myeloma express CD19 and IgHmRNA and have patient-specific IgH VDJ gene rearrangements
12. + cells in the peripheral blood of a patient with multiple myeloma
13. Myeloma cell contamination of peripheral blood stern cell grafts in patients with multiple myeloma treated by high-dose therapy
14. Detection of monoclonal plasma cells in the peripheral blood stem cell harvests of patients with multiple myeloma
15. Detection of malignant B cells in peripheral blood stem cell collections after chemotherapy in patients with multiple myeloma
16. Comparison of myeloma cell contamination of bone marrow and peripheral blood stem cell harvests
17. Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts
18. + cells to remove circulating tumor cells
19. Differential mobilization of myeloma cells and normal hematopoietic stem cells in multipe myeloma after treatment with cyclophosphamide and granulocyte-macrophage colony-stimulating factor
20. Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized controlled trial
21. + cell enumeration in blood and leukapheresis products: Report from the Second Nordic Workshop
22. Reduced bone marrow stem cell pool and progenitor mobilisation in multiple myeloma after melphalan treatment
23. Phenotypic difference of normal plasma cells from mature myeloma cells
24. Circulating clonal cells in multiple myeloma do not express CD34 mRNA, as measured by single-cell and real-time RT-PCR assays
25. Quantitation of minimal residual disease in multiple myeloma using an allele specific real-time PCR assay
26. Improved priming for mobilisation of and optimal timing for harvest of peripheral blood stem cells
27. A comparative study of sequential priming and mobilisation of progenitor cells with rhG-CSF alone and high-dose cyclophospamide plus rhG-CSF
28. First and second apheresis in patients with multiple myeloma: No differences in tumor load and hematopoietic stem cell yield
29. CD34 counts to predict the adequate collection of peripheral blood progenitor cells
30. Monoclonal plasma cells in the blood stem cell harvest from patients with multiple myeloma are associated with shortened relapse-free survival after transplantation
31. The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cell in multiple myeloma
32. Transplantation of CD34 + peripheral blood progenitor cells after high dose chemotherapy for patients with advanced multiple myeloma
33. + selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: Tumour cell contamination and outcome
34. Linear reduction of clonal cells in stem cell enriched grafts in transplanted multiple myeloma
35. + selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma
36. + peripheral blood stem cells: Retained engraftment capability and reduced tumour cell content